GINA TARABISHY: Open Payments
NPI 1073022612 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,096 in 19 payments from 9 companies in 2025. Trend: 2023 $474 · 2024 $704 · 2025 $1,096
Travel & lodging: $581Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 2 | $581 |
| GENZYME CORPORATION | 6 | $228 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| MOTIVA USA, LLC | 1 | $75 |
| Pharming Healthcare, Inc. | 2 | $35 |
| Amgen Inc. | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: DUPIXENT, Motiva Implant Matrix, FASENRA, RUCONEST, TEZSPIRE, AIRSUPRA, RINVOQ, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
